Related references
Note: Only part of the references are listed.Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis
Jacob E. Ollrch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
Parambir S. Dulai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Aurelien Amiot et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
Vince B. C. Biemans et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
Britt Christensen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
Gauthier Pellet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe
Roni Weisshof et al.
JOURNAL OF CROHNS & COLITIS (2019)
The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years
Nadia Pillai et al.
JOURNAL OF CROHNS & COLITIS (2019)
Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis
Jeffrey A. Berinstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
Matthew C. Choy et al.
INFLAMMATORY BOWEL DISEASES (2019)
ACG Clinical Guideline: Ulcerative Colitis in Adults
David T. Rubin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions
Mark G. Ward et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
John G. Williams et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Tacrolimus for the Treatment of Ulcerative Colitis
Katsuyoshi Matsuoka et al.
INTESTINAL RESEARCH (2015)
Patient Preferences for Surgical Versus Medical Therapy for Ulcerative Colitis
Meenakshi Bewtra et al.
INFLAMMATORY BOWEL DISEASES (2014)
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients
Marijana Protic et al.
JOURNAL OF CROHNS & COLITIS (2014)
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie et al.
LANCET (2012)
The pattern and outcome of acute severe colitis
Lotte C. Dinesen et al.
JOURNAL OF CROHNS & COLITIS (2010)
Share Paper
